CryoPort Revenue Up 52% For The Second Quarter Of 2017, Driven By Biopharma

Published: Aug 09, 2017

IRVINE, Calif., Aug. 8, 2017 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW), the world's leading cryogenic logistics company dedicated to the life sciences industry, today announced financial results for the three and six-month periods ended June 30, 2017.

"As the most advanced solutions provider of temperature controlled logistics serving the life sciences, Cryoport is setting the 'gold standard' for reproductive medicine, animal health and biopharma, particularly within the dynamic regenerative medicine market as we position our Company for significant revenue growth for years to come," commented Jerrell Shelton, Cryoport's Chief Executive Officer.

Back to news